← All trials
NCT00119002
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2004
- Primary completion
- Apr 1, 2006
- Completion date
- Apr 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 598
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of UtahLead sponsor
- Hurley Medical CenterCollaborator
- Howard County General HospitalCollaborator
- Michigan State UniversityCollaborator
- New York UniversityCollaborator
- University of UtahOverall official - principal investigator
- Columbia UniversityCollaborator
- University of RochesterCollaborator
- University of MarylandCollaborator
- Johns Hopkins UniversityCollaborator
- University of California, DavisCollaborator
- University of MichiganCollaborator
- Children's National Medical CenterCollaborator
- University of CincinnatiCollaborator
- Harvard UniversityCollaborator
- Washington University in St. LouisCollaborator
- University of PennsylvaniaCollaborator
- State University of New York, BuffaloCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.